Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Mar 24.
doi: 10.1007/s00296-024-05556-x. Online ahead of print.

Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis

Konrad Kaleta  1 , Julia Krupa  1 , Wiktoria Suchy  1 , Anna Sopel  1 , Mariusz Korkosz  2 , Jarosław Nowakowski  3
Affiliations
Review

Endothelial dysfunction and risk factors for atherosclerosis in psoriatic arthritis: overview and comparison with rheumatoid arthritis

Konrad Kaleta et al. Rheumatol Int. .

Abstract

Endothelial dysfunction (ED) is defined as an impairment in the vasodilatory, anti-thrombotic, and anti-inflammatory properties of the cells that make up the lining of blood vessels. ED is considered a key step in the development of atherosclerotic cardiovascular disease. The association between ED and systemic inflammatory diseases is well established. However, the prevalence and clinical significance of ED in psoriatic arthritis (PsA) have been investigated to a lesser extent. This review aims to explore the link between ED and PsA, including ED in macro- and microcirculation, as well as risk factors for its occurrence in PsA and its relationship with atherosclerosis in PsA. Furthermore, the ED in PsA was compared with that of rheumatoid arthritis (RA). Regarding ED in the microcirculation, the coronary flow reserve was found to be significantly reduced in individuals with PsA. The relationship between PsA and macrovascular ED is more pronounced, along with more advanced atherosclerosis detected in patients with PsA. These results are consistent with those obtained in RA studies. On the other hand, arterial stiffness and signs of vascular remodeling were found more frequently in RA than in PsA, with the potential role of efficient anti-TNF treatment in patients with PsA and psoriasis explaining this finding. The impact of ED on cardiovascular diseases and the burden of this risk caused independently by PsA have not yet been precisely established, however, this group of patients requires special attention with regard to cardiovascular events.

Keywords: Arthritis; Atherosclerosis; Endothelium; Psoriatic; Rheumatoid.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic arthritis. N Engl J Med 376:957–970. https://doi.org/10.1056/NEJMra1505557 - DOI - PubMed
    1. Mease PJ, Armstrong AW (2014) Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs 74:423–441. https://doi.org/10.1007/s40265-014-0191-y - DOI - PubMed - PMC
    1. Coates LC, Helliwell PS (2017) Psoriatic arthritis: state of the art review. Clin Med 17:65–70. https://doi.org/10.7861/clinmedicine.17-1-65 - DOI
    1. Ciocon DH, Kimball AB (2007) Psoriasis and psoriatic arthritis: separate or one and the same? Br J Dermatol 157:850–860. https://doi.org/10.1111/j.1365-2133.2007.08148.x - DOI - PubMed
    1. Atzeni F, Turiel M, Boccassini L et al (2011) Cardiovascular involvement in psoriatic arthritis. Reumatismo 63:148–154. https://doi.org/10.4081/reumatismo.2011.148 - DOI - PubMed

LinkOut - more resources

-